Tue. 2 Apr 2024, 8:12am ET
Benzinga
Earnings, Earnings Misses, News
Petros Pharmaceuticals (NASDAQ:PTPI) reported quarterly losses of $(2.17) per share which missed the analyst consensus estimate of $(1.11) by 95.5 percent. This is a 6.9 percent decrease over losses of $(2.03) per share from the same period last year. The company reported quarterly sales of $364.25 thousand which missed the analyst consensus estimate of $1.55 million by 76.50 percent. This is a 54.36 percent decrease over sales of $798.10 thousand the same period last year.